EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

COVID-19 primary infection, reinfection, and its associated clinical presentations

Varuni Makam, Vidyavathi B Chitharagi, Tejashree A, Morubagal Raghavendra Rao, Smitha Chandrashekarappa, Yogeesh D Maheshwarappa

Frontiers in Public Health · 14.04.2026 · 14

DOI: 10.3389/fpubh.2026.1695310 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Public Health, online erschienen am 14.04.2026. Verfasst von Varuni Makam und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, JSS Medical College and Hospital, JSS Academy of Higher Education and Research (JSS AHER), Mysuru, India. Hauptthemen laut MEDLINE: Reinfection, COVID-19. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2), which caused primary COVID-19 infection in millions worldwide, raised significant concerns as viral mutations emerged, leading to reinfections among previously infected and vaccinated individuals. This phenomenon became particularly evident during the second and third waves of the COVID-19 pandemic in India.

Methods

The current study observed the rates of reinfections due to SARS-CoV-2 and their relation to vaccination details by retrospectively analyzing the data of patients who had reinfections during the second and third waves of COVID-19.

Results

Among the 458 study participants, 62/458 (13.54%) with primary infection had confirmed re-infection. Of the 458 people infected with COVID-19 for the first time, 60 (13%) were asymptomatic and 398 (87%) were symptomatic. The most frequently observed symptoms were fever during primary (70.3%) and re-infection (72.58%). A statistically significant association was observed between vomiting symptoms and infection status ( p < 0.01).

Conclusions

SARS-CoV-2 is re-emerging with new variants and varied presentations, posing a challenge to clinicians regarding specific diagnoses. The symptoms of COVID-19 during primary and re-infection did not differ greatly. Although vaccination protects individuals against reinfections, the exact duration of protection remains unknown and may necessitate booster doses at frequent intervals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ReinfectionCOVID-19HumansIndiaMaleRetrospective StudiesFemaleSARS-CoV-2AdultMiddle AgedCOVID-19 VaccinesVaccinationYoung AdultAdolescent

Stichwörter der Autor:innen

COVID-19SARS-CoV-2primary infectionreinfectionvaccination

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Department of Microbiology, JSS Medical College and Hospital, JSS Academy of Higher Education and Research (JSS AHER), Mysuru, India.
  • Department of Community Medicine, JSS Medical College and Hospital, JSS Academy of Higher Education and Research (JSS AHER), Mysuru, India.

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Makam, V., Chitharagi, V. B., A, T., Rao, M. R., Chandrashekarappa, S., & Maheshwarappa, Y. D. (2026). COVID-19 primary infection, reinfection, and its associated clinical presentations. Frontiers in Public Health, 14. https://doi.org/10.3389/fpubh.2026.1695310

Vancouver

Makam V, Chitharagi VB, A T, Rao MR, Chandrashekarappa S, Maheshwarappa YD. COVID-19 primary infection, reinfection, and its associated clinical presentations. Frontiers in Public Health. 2026;14. doi:10.3389/fpubh.2026.1695310

BibTeX
@article{Makam2026,
  author = {Makam, Varuni and Chitharagi, Vidyavathi B and A, Tejashree and Rao, Morubagal Raghavendra and Chandrashekarappa, Smitha and Maheshwarappa, Yogeesh D},
  title = {COVID-19 primary infection, reinfection, and its associated clinical presentations},
  journal = {Frontiers in Public Health},
  year = {2026},
  volume = {14},
  doi = {10.3389/fpubh.2026.1695310}
}
Kostenlos starten →